Investorideas.com - Public Health Agency of #Canada announces funding to help frontline workers communicate the health and safety facts about #cannabis
Wednesday, June 13, 2018
Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSXV: $N.V, TSXV: $KHRN.V, TSX: $TRST.TO, TSX: $ACB.TO, TSXV: $ICC.V
Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; TSXV: $N.V,
TSXV: $KHRN.V, TSX: $TRST.TO, TSX: $ACB.TO, TSXV: $ICC.V
Pt. Roberts, WA; Delta, BC –June 13, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source covering
leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcastsCM - cannabis news and stocks to
watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/06139Potcasts-TSXVNKHRNTRSTACBICC.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts. Today we have news announcements from Namaste Technologies Inc. (TSX-: N), Khiron Life Sciences Corp. (TSX-V: KHRN) , CannTrust Holdings Inc ( TSX:
TRST) , Aurora
Cannabis Inc. (TSX: ACB , OTCQB : ACBFF ) and ICC Labs Inc. (TSX-V: ICC).
Namaste
Technologies Inc. announced that further to its April 25th, 2018
announcement of a Letter of Intent with Pineapple Express Delivery Inc., the
Company has signed a Subscription Agreement to acquire 15% of the share capital
of Pineapple Express Delivery Inc. for $1,000,000. Additionally, Namaste
is pleased to announce that Pineapple Express Delivery Inc. has secured a
Courier Services Agreement with Ample Organics, Canada's leading seed-to-sale
software platform, for same-day cannabis delivery. Both transactions validate
Namaste's position as a leader in cannabis focused technology platforms, and
further demonstrate Namaste's ability to identify these value-added services
aimed at enhancing the user experience. Namaste is optimistic about its equity
investment in Pineapple Express Delivery Inc. and expects to see an immediate
impact to the overall business operation.
Khiron Life
Sciences Corp., a Canadian integrated medical cannabis company with its core
operations in Colombia, announced today that the Company has been registered by
the Colombian Agricultural Institute ("ICA") as an agronomical unit.
Khiron is one of two companies in Colombia to receive this registration.
As a
mandatory requirement for commercializing medical cannabis products in Colombia
for distribution, this milestone positions Khiron to receive the first
allocation of quota to commence commercial cultivation of high THC strains, and
to commence commercial cultivation and production of CBD strains which do not
require quota.
CannTrust
Holdings Inc., one of Canada's leading licensed producers of medical cannabis,
announced the signing of an agreement with Kwantlen Polytechnic University
(KPU) to collaborate on the ongoing development of the university's
non-academic Cannabis Career Training program.
CannTrust,
in partnership with KPU, will assist in the continued development of the
Cannabis Career Training program, with the aim of providing students with the
necessary work skills required for the industry's continually evolving demands.
Delivered in an online format, the program is easily accessible and is in
extremely high demand all across Canada.
Aurora
Cannabis Inc. announced today that it intends to complete a $7 million
investment in Choom Holdings Inc., trading on the CSE as CHOO, whereby Aurora
will receive 9,859,155 common shares from Choom's treasury, priced at $0.71 per
share, representing an 8% ownership interest.
Choom
currently operates two late stage applicants under the Access to Cannabis for Medical Purposes Regulations
("ACMPR"). Choom has agreements in place to acquire two additional
late-stage applicant craft growers in BC and Saskatchewan, including a facility
in Sooke, British Columbia, anticipated to receive its cultivation license from
Health Canada in the third quarter of 2018.
ICC Labs
Inc. announced that KSK Labs, a 100% subsidiary of Global Group Kalapa, of
which ICC Labs recently acquired 25%, subject to TSX Venture Exchange approval,
has closed a presale agreement with a Spain-based company, VenPharma, in order
to distribute cannabidiol (“CBD”) products in Spanish pharmacies and
drugstores.
VenPharma is
a laboratory specialized in natural medicine since its foundation in 1976, with
more than 1,300 points of sales in Spain. The agreed first order is of 140,000
CBD products between sublingual CBD oils of 2% and 10%, CBD creams and
infusions based on hemp, to be distributed through 500 point of sales. The
intention with the next orders is to sell over than 370,000 CBD products
annually through all the 1,300 points of sales.
Investor ideas reminds all listeners to read
our disclaimers and disclosures on the Investorideas.com website and this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
Marijuana
/ Hemp Stocks at Cannabisinvestorideas.com and Investorideas.com
Canadian #Cannabis Stocks “Naturally” Changing the World; New Approaches to Anxiety and Sleep Disorders, Pain Treatment, Drug Delivery and Food Supplements
Canadian #Cannabis Stocks
“Naturally” Changing the World; New Approaches to Anxiety and Sleep Disorders, Pain Treatment,
Drug Delivery and Food Supplements
Companies Mentioned: Aphria (TSX: $APH.TO), EVITRADE
Health Systems (CSE: $EVA.C), Lexaria Biosciences (CSE: $LXX.C), Hempco Food
and Fiber (TSXV: $HEMP.V), Aurora
Cannabis (TSX: $ACB.TO)
Point Roberts, WA, Delta BC – June 13, 2018 – (Investorideas.com
Newswire) Investorideas.com, a global news source and investor resource
covering cannabis stocks issues a sector news alert on Canadian cannabis stocks
introducing natural and organic alternatives to key health issues using
cannabinoids. A global revolution is
taking place in healthcare, life sciences and the food and beverage industry
with applications including treatment of anxiety and sleep disorders, pain
management, drug delivery and food supplements.
Read this news in full at http://www.investorideas.com/news/2018/cannabis/06131CanadianStocks.asp
The global landscape is changing so rapidly that in
some instances, cannabis is now taking on traditional healthcare at par. Troy
Dayton, CEO and Founder of the Arcview Group, told Investor Ideas at the
recently held Arcview Investor Forum in Vancouver B.C., “What’s happening in
Germany is very interesting. They are going to have medical cannabis covered by
insurance. Cannabis is actually going to be on the same playing field as
pharmaceuticals.”
One Canadian stock ready to capitalize on that is
Aphria Inc. (TSX: APH, US OTC: APHQF). In May, Aphria announced that its wholly-owned
subsidiary Nuuvera Deutschland GmbH
acquired a 25.1% interest in Berlin-based Schöneberg Hospital
("Schöneberg" or the "Hospital"). The acquisition
facilitates Deutschland's long-term strategy to educate German physicians and
patients and advance evidence that supports the effectiveness of medical
cannabinoids. It is also the first step in Deutschland's plans to build and
operate pain treatment centers throughout Germany. The acquisition is valued at
€1.2 million.
"With our partnership with Schöneberg, we are
laying the groundwork to be at the forefront of medical services," said
Hendrik Knopp, Managing Director of Deutschland. "We are focused on
bringing a patient-centric approach to medical cannabis in Germany, improving awareness
and education of the therapeutic properties of medical cannabis among doctors
and patients."
"The German market is among the most
attractive opportunities for medical cannabis in the world, and this deal is an
important step towards furthering Deutschland's presence in the country,"
said Vic Neufeld, CEO of Aphria. "Like the clinic model in the Canadian
market, these pain treatment centers will serve an invaluable purpose in
supporting and educating patients, physicians and the German public in the
treatment of pain, including, among other treatments, through the use of
medical cannabis. We are continuing to advance our international strategic
plans with investments such as this that lay the foundation for long-term
sustained growth in every market in which we operate."
Full news: https://ca.finance.yahoo.com/news/aphrias-german-subsidiary-nuuvera-deutschland-120000511.html
Another Canadian company entering the sector has
its origins in natural remedies in healthcare and life sciences, EVITRADE
Health Systems Corp. (CSE:EVA) (OTCQB:AXHLF).
According to
their website: ”The Company is investigating the health effects of various
natural remedies on the health of consumers either alone or in conjunction with
other elements. In focus are various plant-based products that are targeted to
relieve symptoms such as anxiety, sleeplessness, chronic inflammation, fatigue
and high cholesterol. Initial projects will include Astaxanthin, Spirulina and
eventually, Cannabinoids.”
Looking forward, the Company sees additional
potential uses for cannabinoids to include addiction treatment,
anti-inflammatory treatment and epilepsy.
On May 30, 2018, EVITRADE (CSE:EVA) (OTCQB:AXHLF) announced that it had
signed a revised Letter of Intent with Cantech Molecular Research Inc. The
soon-to-be acquired Cantech and/or Cantech Intellectual Property (“IP”)
specializes in systems for the manufacture of highly advanced plants grown
through selective breeding (also known as cultivars) and the production of
quality pharmaceutical products for use in agriculture and medicine.
“With this transaction, the Company is looking to
add yet another valuable and versatile asset in its ongoing bid to become an
influential player in the rapidly growing plant-based pharmaceutical business”,
said C.K. Cheung, CEO.
On May 31, 2018 EVITRADE announced that it made a
voluntary ticker symbol change application with FINRA for the Company’s
quotation on the OTC Markets OTCQB® Venture Market. The symbol is expected to
better reflect the corporate name and its new image. The Company also recently
launched a new website to reflect its expansion in the medical technology,
health and life sciences markets.
EVITRADE continued to offer some insight as to
where it is focussing with the announcement on June 11, 2018; “EVITRADE To
Bring Blockchain Technology to the Hemp Industry”. The Company has signed a Letter of Intent
with Veri-Medical Systems Inc. (“Verimed” or the “Company”) to potentially
acquire the Company which has created a blockchain based “seed-to-sale”
protocol focussed on enhancing the integrity of the sale of Hemp based products
such as cannabidiol (“CBD”).
Cannabis and cannabinoids also offer a new approach
to drug delivery and a Kelowna based company, Lexaria Bioscience Corp. (OTC: LXRP) (CSE: LXX), has developed and out-licensed its disruptive delivery technology
that promotes healthier ingestion methods, lower overall dosing and higher
effectiveness of lipophilic active molecules.
On May 31, 2018,
Lexaria announced that, subject
to ongoing legal and tax analysis, it intends to create two wholly-owned
subsidiaries that will respectively hold the intellectual property related to,
in the case of the first subsidiary, the improved processing and
combustion-free delivery of nicotine and nicotine analogs and, in the case of
the second subsidiary, delivery of non-steroidal anti-inflammatory drugs
(''NSAIDs''), phosphodiesterase (''PDE5'') inhibitors and other active
pharmaceutical ingredients.
This proposed structure more suitably reflects the
distinct customer bases and business applications for each subsidiary, thereby
allowing the Company to focus its future research and consider financing
structures and industry partnerships specifically optimized to each. It is
expected that Lexaria's patented DehydraTECHTM technology will be utilized by
both subsidiaries.
Lexaria recently announced lab test results related
to delivery of nicotine through the gastrointestinal tract and superior
nicotine absorption in animal blood plasma.
Lexaria's technology provides increases in
intestinal absorption rates; more rapid delivery to the bloodstream; and
important taste-masking benefits, for orally administered bioactive molecules
including cannabinoids, vitamins, NSAIDs, PDE5 inhibitors, nicotine and other
molecules.
Full news: https://ca.finance.yahoo.com/news/lexaria-bioscience-corp-structures-nicotine-102500495.html
Natural and organic food trends are on the rise
globally; all you have to do is look at the success of Whole Foods, eventually
bought out by Amazon. Hemp’s history with food goes back to the origins of man
and now has a resurgence - thanks to the global legalization trends and new
technology.
For more than 12 years Hempco Food and Fiber Inc. (TSX-V:HEMP) has been a trusted and
respected pioneer, innovator and provider of premier hemp-based foods and hemp
nutraceuticals. Aurora Cannabis Inc. (TSX:ACB) (OTCQX:ACBFF) saw the value of the
company and owns over 50% of the Company.
Hempco Food and Fiber recently announced its growth
and expansion plans. The Company has signed a distribution agreement with Tree
of Life, the United Kingdom's leading wholesale distributor of natural and
organic products. Tree of Life serves more than 1,200 retailers in the UK and
more than 30 countries worldwide. The agreement provides Hempco with
significantly increased market reach through Tree of Life's large footprint and
share of shelf space in the health food sector.
The relationship with Tree of Life was driven in
part by the recognition of the strong momentum hemp products continue to
experience in the health food market due to its beneficial properties, such as
omega 3's and high plant-based protein content.
The new Planet Hemp Organic Hemp Seed Oil + CBD
Food Supplement line was successfully launched at Europe's biggest Natural and
Organic products tradeshow on April 22-23, 2018. The show, visited by ten
thousand delegates, including distributors and retailers, was very successful
for the Company, both in terms of raising visibility and in generating
commercial traction. Reception of the new product line was positive, with new
orders received.
The Planet Hemp Organic Hemp Seed Oil + CBD Food
Supplement product line, available in Original, Mint and Orange, is the only
product approved by the Vegan and Vegetarian Societies. This is a rapidly
growing segment of the market, and this validation creates significant
differentiating power for Hempco.
Full news: https://ca.finance.yahoo.com/news/hempco-provides-operational-expansion-growth-135500467.html
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, podcasts, company profiles,
interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp news
and investing content includes potcastsCM – podcasts featuring cannabis news and stocks to watch plus
insight from thought leaders and experts. Cannabis content also includes
http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a
cannabis investor group on Linkedin.com, the 420 Cannabis Investor ideas
directory www.420cannabisinvestorideas.com, and Global Cannabis Investing at www.Globalcannabisinvesting.com.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution,social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country. Disclosure : Investorideas was compensated for
this tag article to include EVITRADE Health Systems Corp.- learn more about
costs and services http://www.investorideas.com/News-Upload/
Contact Investorideas.com
800-665-0411
Tuesday, June 12, 2018
Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; (TSX: $WEED.TO), (TSX: $TRST.TO), (CSE: $CRZ.C), (CSE: $IAN.C)
Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; (TSX:
$WEED.TO), (TSX: $TRST.TO), (CSE:
$CRZ.C), (CSE:
$IAN.C)
Pt. Roberts, WA; Delta, BC –June 12, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcastsCM - cannabis news and stocks to
watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/06122Potcasts-TSXWEEDTRSTCSECRZIAN.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast –
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts. Today we are looking at announcements from Canopy Growth
Corporation (TSX: WEED and NYSE: CGC), CannTrust Holdings Inc. (TSX: TRST), CannaRoyalty Corp. (CSE: CRZ and OTCQX: CNNRF) and iAnthus
Capital Holdings, Inc. (CSE: IAN and OTCQB: ITHUF).
Canopy Growth Corporation provided updates on its medical cannabis
program and re-affirmed its strong commitment to medical cannabis, the patients
who depend on it, and the Healthcare Professionals who prescribe it.
Marking a major milestone for medical cannabis in Canada, a Phase IIb
"in-human" clinical trial application was submitted by Canopy Health
Innovations Inc. to evaluate the use of medical cannabis in the treatment of
insomnia. Having received approval to proceed with these clinical trials in the
form of a No Objection Letter (NOL) from Health Canada, Canopy Health will now
proceed with these robust clinical trials, in collaboration with a leading
Canadian research institution.
Also, as previously announced, starting in July 2018, Dr. Mark Ware
will commence his role as the Company's Chief Medical Officer. Under
his leadership the Company will continue to lead the global medical
cannabis industry forward with a focus on research, product innovation,
and stakeholder education in the numerous regions where Spectrum Cannabis
operates, including Latin America, Australia, Europe and North America.
Finally, in order to honor the company’s commitment to affordable medical
cannabis and pricing predictability for patients, Canopy Growth announced that
upon the passing of the Cannabis Act, the Company will absorb the proposed
excise tax on all Spectrum Cannabis products sold in Canada. Affordability is a
key consideration for patients. It is important today to show leadership and
reduce the price burden placed on our customers,while we work towards insurance
eligibility for medical cannabis.
On top of this, all Spectrum Cannabis dried flower products will be
priced at $8.50 per gram or less. If a registered customer is currently paying
more for a Spectrum flower product this means new savings, and if they are
paying less that price will remain the same. As always, Spectrum Cannabis
products available online through TweedMainStreet.com are eligible for our
industry-first Compassionate Pricing Program that assists those on limited
incomes afford their medicine.
CannTrust Holdings Inc., one of Canada's leading licensed producers of
medical cannabis, announced the signing of a memorandum of understanding with
Niagara College to collaborate in the development of the College's Commercial
Cannabis Production (CCP) Graduate Certificate program. The program will
strengthen CannTrust's workforce production capabilities and help fill the
growing demand for knowledgeable employees in the booming cannabis industry.
With the
launch of this new program, Niagara College will become the first Canadian
post-secondary institution to offer credits in Commercial Cannabis Production.
CannTrust will be awarding six students with scholarships as part of the
program's inauguration. The College and CannTrust are excited to be
participating in shaping the future of Canada's cannabis industry and look
forward to welcoming the program's first student intake in September 2018.
CannaRoyalty Corp., a leading
North American cannabis products and brands company, announced today that its
investee company Anandia Laboratories Inc. has signed a binding term sheet to
be acquired by Aurora Cannabis Inc. for approximately $115 million.
CannaRoyalty owns 16.5% of Anandia, and its equity stake is valued at approximately
$19 million based on the acquisition valuation, representing an almost 400%
return on investment.
This
acquisition advances CannaRoyalty's stated strategy of partnering or
rationalizing select assets that the Company has deemed non-core to its go-forward
strategy and more valuable to other parties. The proceeds will be used to fund
expansion and further acquisitions without dilution for shareholders and the
acquisition by one of Canada's largest LPs validates the significant long-term
potential that CannaRoyalty identified in the analytics, testing and genetics
verticals.
iAnthus
Capital Holdings, Inc., which owns, operates, and partners with licensed
cannabis operations throughout the United States, announced today that
Mayflower Medicinals, Inc. has signed a Host Community Agreement with the City
of Lowell, Massachusetts, to operate a Medical Marijuana Treatment Center
located at 450 Chelmsford Street. Lowell, Massachusetts.
Mayflower
intends to diligently pursue a Special Permit at the site. If granted,
the dispensary is expected to be one of only two operating dispensaries within
the Lowell city limits.
"The
Commonwealth of Massachusetts and the City of Lowell have abided by high
program standards that are firmly focused on patient care and regulatory
compliance," said John Henderson, Chief Development Officer of iAnthus.
"Mayflower is honored to have successfully completed its host community
agreement with Lowell, which adds significant value to the project by
documenting a supportive relationship between the City and the development of
the Registered Marijuana Dispensary site."
Investor ideas reminds all listeners to read
our disclaimers and disclosures on the Investorideas.com website and this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com
, the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
Marijuana
/ Hemp Stocks at Cannabisinvestorideas.com and Investorideas.com
Subscribe to:
Posts (Atom)